Literature DB >> 23618617

A review of renal disease in cystic fibrosis.

Dilip Nazareth1, Martin Walshaw.   

Abstract

Kidney disease is becoming increasingly common in CF. This review looks at the effect of CFTR on the kidney, the problems with measuring renal function effectively in CF, the causes and incidence of renal dysfunction, and its pathophysiology. Strategies to reduce aminoglycoside toxicity are discussed.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23618617     DOI： 10.1016/j.jcf.2013.03.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


  15 in total

1.  The association of acute kidney injury with the concomitant use of vancomycin and piperacillin/tazobactam in children: A systematic review and meta-analysis.

Authors:  Markos Kalligeros; Spyridon A Karageorgos; Fadi Shehadeh; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

Review 2.  Advances in our understanding of genetic kidney disease using kidney organoids.

Authors:  Melissa H Little; Catherine Quinlan
Journal:  Pediatr Nephrol       Date:  2019-05-07       Impact factor: 3.714

3.  Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.

Authors:  Florian Stehling; Rainer Büscher; Jörg Grosse-Onnebrink; Peter F Hoyer; Uwe Mellies
Journal:  Pulm Med       Date:  2017-01-04

4.  Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis.

Authors:  Jie Ting Zhang; Yan Wang; Jun Jiang Chen; Xiao Hu Zhang; Jian Da Dong; Lai Ling Tsang; Xiao Ru Huang; Zhiming Cai; Hui Yao Lan; Xiao Hua Jiang; Hsiao Chang Chan
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

Review 5.  Imaging the Abdominal Manifestations of Cystic Fibrosis.

Authors:  C D Gillespie; M K O'Reilly; G N Allen; S McDermott; V O Chan; C A Ridge
Journal:  Int J Hepatol       Date:  2017-01-29

Review 6.  Cystic Fibrosis-Related Diabetes.

Authors:  Kayani Kayani; Raihan Mohammed; Hasan Mohiaddin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

7.  Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis.

Authors:  Silvia Lai; Sandro Mazzaferro; Anna Paola Mitterhofer; Enea Bonci; Paolo Giangreco Marotta; Francesco Pelligra; Manuel Murciano; Camilla Celani; Patrizia Troiani; Giuseppe Cimino; Paolo Palange
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

Review 8.  Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Drugs R D       Date:  2016-03

9.  The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis.

Authors:  Mohamed Al-Aloul; Dilip Nazareth; Martin Walshaw
Journal:  Clin Kidney J       Date:  2019-02-07

Review 10.  Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.

Authors:  Adam J Causer; Janis K Shute; Michael H Cummings; Anthony I Shepherd; Mathieu Gruet; Joseph T Costello; Stephen Bailey; Martin Lindley; Clare Pearson; Gary Connett; Mark I Allenby; Mary P Carroll; Thomas Daniels; Zoe L Saynor
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.